These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26358892)

  • 1. Recent advances and applications of metabolomics to investigate neurodegenerative diseases.
    Ibáñez C; Cifuentes A; Simó C
    Int Rev Neurobiol; 2015; 122():95-132. PubMed ID: 26358892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomics of neurodegenerative diseases.
    Botas A; Campbell HM; Han X; Maletic-Savatic M
    Int Rev Neurobiol; 2015; 122():53-80. PubMed ID: 26358890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in metabolomics in neurological disease, and future perspectives.
    Zhang AH; Sun H; Wang XJ
    Anal Bioanal Chem; 2013 Oct; 405(25):8143-50. PubMed ID: 23715678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Biomarkers and Neurodegeneration: A Pathway Enrichment Analysis of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.
    Kori M; Aydın B; Unal S; Arga KY; Kazan D
    OMICS; 2016 Nov; 20(11):645-661. PubMed ID: 27828769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics Approach to Identify Biomarkers in Neurodegenerative Diseases.
    Nayak A; Salt G; Verma SK; Kishore U
    Int Rev Neurobiol; 2015; 121():59-86. PubMed ID: 26315762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Potential of Proteomics in Understanding Neurodegeneration.
    Pal R; Larsen JP; Moller SG
    Int Rev Neurobiol; 2015; 121():25-58. PubMed ID: 26315761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoporosis in neurodegeneration.
    Roos PM
    J Trace Elem Med Biol; 2014 Oct; 28(4):418-21. PubMed ID: 25220531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroproteomics tools in clinical practice.
    Shevchenko G; Konzer A; Musunuri S; Bergquist J
    Biochim Biophys Acta; 2015 Jul; 1854(7):705-17. PubMed ID: 25680928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical proteomics in neurodegenerative disorders.
    Zetterberg H; Rüetschi U; Portelius E; Brinkmalm G; Andreasson U; Blennow K; Brinkmalm A
    Acta Neurol Scand; 2008 Jul; 118(1):1-11. PubMed ID: 18279484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of protein aggregation in neurodegenerative disease.
    Pedersen JT; Heegaard NH
    Anal Chem; 2013 May; 85(9):4215-27. PubMed ID: 23472885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA damage in neurodegenerative diseases.
    Coppedè F; Migliore L
    Mutat Res; 2015 Jun; 776():84-97. PubMed ID: 26255941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Mesenchymal Stem Cells in Counteracting Oxidative Stress-Related Neurodegeneration.
    Angeloni C; Gatti M; Prata C; Hrelia S; Maraldi T
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32392722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Unbiased Search of Biomarkers in Neurodegenerative Diseases.
    Ferrara P
    Curr Pharm Biotechnol; 2016; 17(5):471-9. PubMed ID: 26956112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomics of human brain aging and age-related neurodegenerative diseases.
    Jové M; Portero-Otín M; Naudí A; Ferrer I; Pamplona R
    J Neuropathol Exp Neurol; 2014 Jul; 73(7):640-57. PubMed ID: 24918636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Proteomics for the Evaluation of Protein Expression and Modifications in Neurodegenerative Diseases.
    Conti A; Alessio M
    Int Rev Neurobiol; 2015; 121():117-52. PubMed ID: 26315764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomics in degenerative brain diseases.
    Quintero ME; Pontes JGM; Tasic L
    Brain Res; 2021 Dec; 1773():147704. PubMed ID: 34744014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive oxygen species: stuck in the middle of neurodegeneration.
    Patten DA; Germain M; Kelly MA; Slack RS
    J Alzheimers Dis; 2010; 20 Suppl 2():S357-67. PubMed ID: 20421690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipidomics applications for disease biomarker discovery in mammal models.
    Zhao YY; Cheng XL; Lin RC; Wei F
    Biomark Med; 2015; 9(2):153-68. PubMed ID: 25689902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of Disease: astrocytes in neurodegenerative disease.
    Maragakis NJ; Rothstein JD
    Nat Clin Pract Neurol; 2006 Dec; 2(12):679-89. PubMed ID: 17117171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2D gel blood serum biomarkers reveal differential clinical proteomics of the neurodegenerative diseases.
    Sheta EA; Appel SH; Goldknopf IL
    Expert Rev Proteomics; 2006 Feb; 3(1):45-62. PubMed ID: 16445350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.